Facebook
Twitter
LinkedIn
Forward7th Annual Gastroenterology & Hepatology Update with Interactive Live Endoscopy - 2021 - LIVESTREAM - Friday/Saturday
Course Directors: Norio Fukami, M.D., Thomas J. Byrne, M.D.
This course will provide the latest, state-of-the-art information on the diagnosis and management of common disorders such as colon polyps; IBS, Celiac disease, Eosinophilic esophagitis, Barrett’s esophagus, gallstones and bile duct stones, Artificial Intelligence in GI endoscopy, new interventional Endoscopic Ultrasound (EUS); strategies for screening for and managing hepatocellular carcinoma in populations, hepatitis B treatment, and management and diagnosis of fatty liver disease. Friday will offer a full-day interactive live-endoscopy session where participants will have the unique opportunity to ask the endoscopists questions while the procedures are taking place. And Saturday will offer didactic lectures with panel discussions for interactive Q & A opportunities with the faculty members. Active audience participation is strongly encouraged. Course highlights:
|
Target Audience
The intended audience includes gastroenterologists, primary care physicians, nurses and advanced healthcare practitioners (NPs, PAs, RNs, etc.).
Learning Objectives
Upon completion of this activity, participants should be able to:
Gastroenterology:
• Review updated diagnostic criteria and management for IBS
• Explain expanding possibilities of interventional Endoscopic Ultrasound
• Describe diagnostic criteria and new treatment modalities for Eosinophilic esophagitis
• Evaluate upcoming AI technology in diagnostic endoscopy
• Describe the best technique to achieve high-quality EMR for managing colon polyps
• Evaluate current recommendations and newer diagnostic modalities for Barrett’s esophagus
• Review current algorithm to evaluate and treat suspected gallstone disease and bile duct stone
Hepatology:
• Evaluate current management for alcoholic hepatitis, including the controversial role of liver transplantation, and assess emerging potential therapy
• Update current and emerging approaches to hepatitis B
• Appraise current management of fatty liver disease
• Review strategies for screening populations for and managing hepatocellular carcinoma
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
ng expenses are the sole responsibility of the individual registrant.
Mayo Faculty
Thomas J. Byrne, M.D.
Douglas O. Faigel, M.D.
Norio Fukami, M.D.
Jennifer L. Horsley-Silva, M.D.
Allon Kahn, M.D.
Tisha N. Lunsford, M.D.
Rahul Pannala, M.D.
Francisco C. Ramirez, M.D.
Louis M. Wong Kee Song, M.D.
Guest Faculty
Viveksandeep Thoguluva Chandrasekar, M.D.
University of Kansas Hospital
Syracuse, NY
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| Day | Credit |
|---|---|
| Friday | 8.00 |
| Saturday | 5.00 |
ANCC
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 13.0 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
AAFP
The AAFP has reviewed 7th Annual Gastroenterology & Hepatology Update with Interactive Live Endoscopy Session and deemed it acceptable for up to 13.00 In-Person, Live (could include online) AAFP Prescribed credit. Term of Approval is from 10/01/2021 to 10/02/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOA
This program has been accredited by the American Osteopathic Association for 13.0 credits of AOA Category 2-A.
MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 13.00 AAFP Prescribed
- 13.00 AAPA Category 1
- 13.00 ABIM
- 13.00 AMA PRA Category 1 Credit™
- 13.00 ANCC
- 13.00 AOA Category 2-A
- 13.00 Attendance
For information regarding exhibit opportunities, please reach out to Kristy Badder.
Price
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.